| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/02/2008 | CN100358874C 3,4-dihydroquinazoline derivatives as t-type calcium channel blockers and method of preparing the same |
| 01/02/2008 | CN100358869C Carbamate caspase inhibitors and uses thereof |
| 01/02/2008 | CN100358867C Heterocyclic inhibitors of glycogen synthase kinase GSK-3 |
| 01/02/2008 | CN100358862C 2,5-bis-diamine-[1,4] benzoquinone derivatives for the treatment of alzheimer's disease, a process for their preparation and intermediates therefor |
| 01/02/2008 | CN100358595C Safety shield system for prefilled syringe |
| 01/02/2008 | CN100358577C Treatment of auto immune diseases with antagonists which bind to B cell surface markers |
| 01/02/2008 | CN100358576C Medicine and food dual purpose Chinese medicinal nutritive product for preventing and treating alcoholism and its manufacturing method |
| 01/02/2008 | CN100358546C Process for preparing Chinese medicine compound dripping pill for treating headaches |
| 01/02/2008 | CN100358533C Medicinal composition for drug-induced neuropathy |
| 01/02/2008 | CN100358520C Edalavon powder for ampoul injection having good stability and its preparation method |
| 01/02/2008 | CN100358515C Treatment of neurodegenerative and cardiovascular disorders |
| 01/02/2008 | CN100358504C Gastrodia brain arousing drip pill for nourishing liver and kidney and its preparation method |
| 01/02/2008 | CN100358502C Acanthopanax root dripping pill and its preparing method |
| 01/02/2008 | CN100358501C Tranquilizing wild jujube seed dripping pill and its preparing method |
| 01/02/2008 | CN100358494C Inhalation system |
| 01/02/2008 | CN100358492C Preparation of Chinese traditional medicine for curing headache and preparation method |
| 01/01/2008 | US7314940 For therapy and prophylaxis of neurodegenerative disorders related to apoptosis and/or inflammation |
| 01/01/2008 | US7314936 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |
| 01/01/2008 | US7314934 Substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors |
| 01/01/2008 | US7314930 Reducing 2-nitro-2'-carboxy-diphenylsulfide derivative in presence of hydrogen gas and reduction catalyst; subjecting 2-amino-2'-carboxy-diphenylsulfide derivative to dehydration-condensation to produce dibenzo[b,f][1,4]thiazepin-11-one compound |
| 01/01/2008 | US7314914 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
| 01/01/2008 | US7314889 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 01/01/2008 | US7314883 (+-)-3-(1H-Indazol-5-yl)-2-{[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carbonyl]-amino}-propionic acid to treat neurogenic vasodilation, neurogenic inflammaton, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases |
| 01/01/2008 | US7314881 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds |
| 01/01/2008 | US7314878 Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or CNS disorders |
| 01/01/2008 | US7314870 Compounds, their preparation and use |
| 01/01/2008 | US7314864 Isolated polypeptid of 24-amino acids; the clone suppressed neuronal death induced by all of the known types of early-onset familial Altzheimers Disease genes |
| 01/01/2008 | US7314642 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants |
| 01/01/2008 | US7314633 Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof |
| 01/01/2008 | US7314617 Platelet rich plasma, no exogenous activator; sodium bicarbonate buffer, citrate dextrose anticoagulant |
| 12/30/2007 | CA2593613A1 Novel naphthalene derivatives, process for their preparation and pharmaceutical compositions containing them |
| 12/27/2007 | WO2007150064A2 METHOD FOR THE TREATMENT OF NEUROLOGICAL DISORDERS BY ENHANCING THE ACTIVITY OF β-GLUCOCEREBROSIDASE |
| 12/27/2007 | WO2007150010A2 Cyclopropyl amine derivatives as histamin h3 receptor modulators |
| 12/27/2007 | WO2007149929A1 Piperidine derivatives for the treatment of gastrointestinal and cns disorders |
| 12/27/2007 | WO2007149557A1 FUSED [d]PYRIDAZIN-7-ONES |
| 12/27/2007 | WO2007149508A2 Non-competitive nmda receptor antagonists |
| 12/27/2007 | WO2007149451A2 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 12/27/2007 | WO2007149033A1 Substituted isoindoles as bace inhibitors and their use |
| 12/27/2007 | WO2007149030A1 Novel heteroaryl substituted benzoxazoles |
| 12/27/2007 | WO2007148950A1 Synergistic pharmaceutical composition of ketorolac and lysine clonixinate |
| 12/27/2007 | WO2007148711A1 N-(3,4-disubstituted phenyl)salicylamide derivative |
| 12/27/2007 | WO2007148697A1 Inhibitor of expression of nuclear transcription factor ap-1, and pharmaceutical product and product using the inhibitor |
| 12/27/2007 | WO2007148648A1 Therapeutic or prophylactic agent for multiple sclerosis |
| 12/27/2007 | WO2007148494A1 Agent for increasing testosterone level |
| 12/27/2007 | WO2007148307A1 Compositions and kits comprising a melatonin component and a chondroprotective component |
| 12/27/2007 | WO2007148208A2 Carbonylated (aza) cyclohexanes as dopamine d3 receptor ligands |
| 12/27/2007 | WO2007148113A1 Metabotropic glutamate receptor modulators |
| 12/27/2007 | WO2007148103A1 Crystalline duloxetine hydrochloride |
| 12/27/2007 | WO2007148096A1 Crystalline duloxetine hydrochloride |
| 12/27/2007 | WO2007148094A1 Cannabinoids for use in the treatment of neuropathic pain |
| 12/27/2007 | WO2007148062A1 Therapeutic agents |
| 12/27/2007 | WO2007148061A1 Therapeutic agents |
| 12/27/2007 | WO2007147883A1 Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity |
| 12/27/2007 | WO2007147836A1 Glycine transporter inhibiting compounds and uses in medicine |
| 12/27/2007 | WO2007147834A1 Glycine transporter inhibiting compounds and uses in medicine |
| 12/27/2007 | WO2007147831A1 Pyrrolidine derivatives having activity at the glyt1 transporter |
| 12/27/2007 | WO2007147819A1 3h,11h-oxazolo[3',4':1,2]pyrido[3,4-b]indole derivatives and therapeutic use thereof |
| 12/27/2007 | WO2007147771A2 Tetralin and indane derivatives and uses thereof |
| 12/27/2007 | WO2007147770A2 Substituted phenyl methanone derivatives |
| 12/27/2007 | WO2007147763A1 Arylsulfonyl naphthalene derivatives and uses thereof |
| 12/27/2007 | WO2007147762A1 Arylsulfonamidyl tetralin derivatives and uses thereof |
| 12/27/2007 | WO2007147746A1 2-pyrazinecarboxamide derivatives |
| 12/27/2007 | WO2007147577A1 Quinazoline derivatives, their preparation, their use as tyrosine kinase inhibitors and medicaments comprising them |
| 12/27/2007 | WO2007147346A1 Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof |
| 12/27/2007 | WO2007147330A1 The application of the bakuchiol compounds |
| 12/27/2007 | WO2007130821A3 Mglur5 modulators ii |
| 12/27/2007 | WO2007125321A3 Purine and deazapurine derivatives as pharmaceutical compounds |
| 12/27/2007 | WO2007118325A8 Enhancement of memory and/or cognition using substituted butyrophenone compounds |
| 12/27/2007 | WO2007115077A3 Bicyclic benzimidazole compounds and their use as metabotropic glutamate receptor potentiators |
| 12/27/2007 | WO2007106708A3 Combinations of the angiotensin ii antagonist valsartan and the nep inhibitor daglutril |
| 12/27/2007 | WO2007047305A8 Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors |
| 12/27/2007 | WO2007045593A3 Naphthyl derivatives as inhibitors of beta-amyloid aggregation |
| 12/27/2007 | WO2006128142A8 Inhibitors of cytosolic phospholipase a2 |
| 12/27/2007 | US20070299263 Hydroxy Alkyl Amines |
| 12/27/2007 | US20070299126 Substituted pyrrole-indoles |
| 12/27/2007 | US20070299118 Benzoxazolone Derivatives, Processes For Preparing Them And Their Uses |
| 12/27/2007 | US20070299117 Hydroxypropylaimines |
| 12/27/2007 | US20070299112 Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i |
| 12/27/2007 | US20070299111 Benzamide derivatives and uses related thereto |
| 12/27/2007 | US20070299110 Novel Tetrazole Derivatives as Positive Allosteric Modulators of Metabotropic Glutamate |
| 12/27/2007 | US20070299109 Dimeric Compounds Of Piperidine, Piperazine Or Morpholine Or Their 7-Membered Analogs Suitable For The Treatment Of Neurodegenerative Disorders |
| 12/27/2007 | US20070299098 Therapeutic Agent for Neuropathic Pain |
| 12/27/2007 | US20070299096 Treating Learning Deficits With Inhibitors of Hmg CoA Reductase |
| 12/27/2007 | US20070299093 Organic Compounds Useful for the Treatment of Alzheimer's Disease, Their Use and Method of Preparation |
| 12/27/2007 | US20070299090 Substituted 8-aminoalkoxy-xanthine compounds and compositions useful in the treatment of hyperlipidemia and diabetes |
| 12/27/2007 | US20070299088 Novel Uses of 2-Phenyl-Substituted Imidazotriazinone Derivatives |
| 12/27/2007 | US20070299087 New Compounds 319 |
| 12/27/2007 | US20070299083 6-Methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts |
| 12/27/2007 | US20070299082 (+-)-3-(6-Phenylethynyl-pyridazin-3-yloxy)-1-aza-bicyclo[2.2.2]octane; (+-)-N-{4-[6-(1-Aza-bicyclo[2.2.2]oct-3-yloxy)-pyridazin-3-ylethynyl]-phenyl}-acetamide; nicotinic and monoamine receptor modulators |
| 12/27/2007 | US20070299079 4-AMINO-PYRIDO[3,2-e]PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM |
| 12/27/2007 | US20070299075 e.g. 1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-4-(aminosulfonyl)aminobutan-2-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent |
| 12/27/2007 | US20070299074 Guanidine Compounds, and Use Thereof as Binding partners for 5-Ht5 Receptors |
| 12/27/2007 | US20070299073 Imidazolyl derivatives |
| 12/27/2007 | US20070299072 Kv1.5 potassium channel inhibitors |
| 12/27/2007 | US20070299070 Such as 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-indole-2-carboxamide and 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-benzimidazole-2-carboxamide; melanin-concentrating hormone receptor antagonist, useful for treating obesity |
| 12/27/2007 | US20070299067 Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors |
| 12/27/2007 | US20070299058 Anxiolytic Agents With Reduced Sedative And Ataxic Effects |
| 12/27/2007 | US20070299056 Benzazepine derivatives for the treatment of neurological disorders |
| 12/27/2007 | US20070299053 N-(2-hydroxy-3-methyl-butyryl)-1-(L-alaninyl)-1-amino-3-methyl-4,5,6,7-tetrahydro-2H-3-benzazepin-2-one; inhibiting beta amyloid peptide release and/or synthesis |
| 12/27/2007 | US20070299050 TNF alpha inhibitors; inflammatory diseases such as rheumatoid arthritis, Crohn's disease, septic shock syndrome and atherosclerosis |